{"id":"https://openalex.org/W2783422013","doi":"https://doi.org/10.1080/0284186x.2017.1423375","title":"Predictive factors of thromboembolic complications in patients with esophagogatric adenocarcinoma undergoing preoperative chemotherapy","display_name":"Predictive factors of thromboembolic complications in patients with esophagogatric adenocarcinoma undergoing preoperative chemotherapy","publication_year":2018,"publication_date":"2018-01-08","ids":{"openalex":"https://openalex.org/W2783422013","doi":"https://doi.org/10.1080/0284186x.2017.1423375","mag":"2783422013","pmid":"https://pubmed.ncbi.nlm.nih.gov/29308947"},"language":"en","primary_location":{"id":"doi:10.1080/0284186x.2017.1423375","doi":"https://doi.org/10.1080/0284186x.2017.1423375","is_oa":true,"landing_page_url":"https://doi.org/10.1080/0284186x.2017.1423375","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2017.1423375?needAccess=true&role=button","source":{"id":"https://openalex.org/S1043257","display_name":"Acta Oncologica","issn_l":"0284-186X","issn":["0284-186X","1651-226X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Oncologica","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2017.1423375?needAccess=true&role=button","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070188844","display_name":"George Papaxoinis","orcid":"https://orcid.org/0000-0001-6900-784X","observed_orcids":["https://orcid.org/0000-0001-6900-784X"]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4210133995","display_name":"The Christie NHS Foundation Trust","ror":"https://ror.org/03v9efr22","country_code":"GB","type":"funder","lineage":["https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"George Papaxoinis","raw_affiliation_strings":["Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK;","institution_ids":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074378231","display_name":"Konstantinos Vellios Kamposioras","orcid":"https://orcid.org/0000-0003-3506-1500","observed_orcids":["https://orcid.org/0000-0003-3506-1500"]},"institutions":[{"id":"https://openalex.org/I4210160067","display_name":"Mid Yorkshire Hospitals NHS Trust","ror":"https://ror.org/05g23q746","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210160067"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Konstantinos Kamposioras","raw_affiliation_strings":["Department of Medical Oncology, The Mid Yorkshire Hospitals NHS Trust, Wakefield, UK;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, The Mid Yorkshire Hospitals NHS Trust, Wakefield, UK;","institution_ids":["https://openalex.org/I4210160067"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002070644","display_name":"Theodora Germetaki","orcid":"https://orcid.org/0000-0003-2252-7471","observed_orcids":["https://orcid.org/0000-0003-2252-7471"]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4210133995","display_name":"The Christie NHS Foundation Trust","ror":"https://ror.org/03v9efr22","country_code":"GB","type":"funder","lineage":["https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Theodora Germetaki","raw_affiliation_strings":["Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK;","institution_ids":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089303857","display_name":"Jamie M. J. Weaver","orcid":"https://orcid.org/0000-0003-0112-9044","observed_orcids":["https://orcid.org/0000-0003-0112-9044"]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4210133995","display_name":"The Christie NHS Foundation Trust","ror":"https://ror.org/03v9efr22","country_code":"GB","type":"funder","lineage":["https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jamie M. J. Weaver","raw_affiliation_strings":["Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK;","institution_ids":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030556284","display_name":"Sofia Stamatopoulou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4210133995","display_name":"The Christie NHS Foundation Trust","ror":"https://ror.org/03v9efr22","country_code":"GB","type":"funder","lineage":["https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sofia Stamatopoulou","raw_affiliation_strings":["Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK;","institution_ids":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113710549","display_name":"Magdy Nasralla","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4210133995","display_name":"The Christie NHS Foundation Trust","ror":"https://ror.org/03v9efr22","country_code":"GB","type":"funder","lineage":["https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Magdy Nasralla","raw_affiliation_strings":["Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK;","institution_ids":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021051331","display_name":"Zoe Kordatou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4210133995","display_name":"The Christie NHS Foundation Trust","ror":"https://ror.org/03v9efr22","country_code":"GB","type":"funder","lineage":["https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Zoe Kordatou","raw_affiliation_strings":["Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK;","institution_ids":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046732028","display_name":"Vikki Owen-Holt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4210133995","display_name":"The Christie NHS Foundation Trust","ror":"https://ror.org/03v9efr22","country_code":"GB","type":"funder","lineage":["https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Vikki Owen-Holt","raw_affiliation_strings":["Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK;","institution_ids":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080693514","display_name":"Alan Anthoney","orcid":"https://orcid.org/0000-0001-5695-8312","observed_orcids":["https://orcid.org/0000-0001-5695-8312"]},"institutions":[{"id":"https://openalex.org/I2799390153","display_name":"Leeds Teaching Hospitals NHS Trust","ror":"https://ror.org/00v4dac24","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799390153"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Alan Anthoney","raw_affiliation_strings":["Department of Medical Oncology, The Leeds Teaching Hospitals NHS Trust, Leeds, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, The Leeds Teaching Hospitals NHS Trust, Leeds, UK","institution_ids":["https://openalex.org/I2799390153"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5074217604","display_name":"Wasat Mansoor","orcid":"https://orcid.org/0000-0002-1477-4934","observed_orcids":["https://orcid.org/0000-0002-1477-4934"]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4210133995","display_name":"The Christie NHS Foundation Trust","ror":"https://ror.org/03v9efr22","country_code":"GB","type":"funder","lineage":["https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Wasat Mansoor","raw_affiliation_strings":["Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK;","institution_ids":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5074217604"],"corresponding_institution_ids":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"],"apc_list":null,"apc_paid":null,"fwci":1.4732,"has_fulltext":true,"cited_by_count":14,"citation_normalized_percentile":{"value":0.85312741,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"57","issue":"6","first_page":"790","last_page":"798"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11355","display_name":"Inflammatory Biomarkers in Disease Prognosis","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/esophagogastric-adenocarcinoma","display_name":"esophagogastric adenocarcinoma","score":0.9380000233650208},{"id":"https://openalex.org/keywords/thromboembolic-events","display_name":"thromboembolic events","score":0.8960000276565552},{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.949999988079071},{"id":"https://openalex.org/keywords/pulmonary-embolism","display_name":"pulmonary embolism","score":0.777999997138977},{"id":"https://openalex.org/keywords/deep-vein-thrombosis","display_name":"deep vein thrombosis","score":0.9950000047683716},{"id":"https://openalex.org/keywords/myocardial-infarction","display_name":"myocardial infarction","score":0.8370000123977661},{"id":"https://openalex.org/keywords/central-venous-access-devices","display_name":"central venous access devices","score":0.7409999966621399},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.7429999709129333},{"id":"https://openalex.org/keywords/anticoagulation","display_name":"anticoagulation","score":0.7269999980926514},{"id":"https://openalex.org/keywords/risk-factors","display_name":"risk factors","score":0.7789999842643738}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9776366949081421},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.5268917083740234},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5045057535171509},{"id":"https://openalex.org/C2776265017","wikidata":"https://www.wikidata.org/wiki/Q220570","display_name":"Pulmonary embolism","level":2,"score":0.4930998980998993},{"id":"https://openalex.org/C2781182431","wikidata":"https://www.wikidata.org/wiki/Q356033","display_name":"Adenocarcinoma","level":3,"score":0.46761903166770935},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.45313093066215515},{"id":"https://openalex.org/C2780835546","wikidata":"https://www.wikidata.org/wiki/Q425122","display_name":"Epirubicin","level":4,"score":0.4520573019981384},{"id":"https://openalex.org/C2780011451","wikidata":"https://www.wikidata.org/wiki/Q2751330","display_name":"Venous thrombosis","level":3,"score":0.44818663597106934},{"id":"https://openalex.org/C50440223","wikidata":"https://www.wikidata.org/wiki/Q1475848","display_name":"Risk factor","level":2,"score":0.4102801978588104},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3843711018562317},{"id":"https://openalex.org/C2780868729","wikidata":"https://www.wikidata.org/wiki/Q261327","display_name":"Thrombosis","level":2,"score":0.3790385127067566},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.36316680908203125},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.14985036849975586}],"mesh":[{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004938","descriptor_name":"Esophageal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004943","descriptor_name":"Esophagogastric Junction","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013274","descriptor_name":"Stomach Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D013923","descriptor_name":"Thromboembolism","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D013923","descriptor_name":"Thromboembolism","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017024","descriptor_name":"Chemotherapy, Adjuvant","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D017024","descriptor_name":"Chemotherapy, Adjuvant","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D020360","descriptor_name":"Neoadjuvant Therapy","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D020360","descriptor_name":"Neoadjuvant Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1080/0284186x.2017.1423375","doi":"https://doi.org/10.1080/0284186x.2017.1423375","is_oa":true,"landing_page_url":"https://doi.org/10.1080/0284186x.2017.1423375","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2017.1423375?needAccess=true&role=button","source":{"id":"https://openalex.org/S1043257","display_name":"Acta Oncologica","issn_l":"0284-186X","issn":["0284-186X","1651-226X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Oncologica","raw_type":"journal-article"},{"id":"pmid:29308947","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29308947","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta oncologica (Stockholm, Sweden)","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1080/0284186x.2017.1423375","doi":"https://doi.org/10.1080/0284186x.2017.1423375","is_oa":true,"landing_page_url":"https://doi.org/10.1080/0284186x.2017.1423375","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2017.1423375?needAccess=true&role=button","source":{"id":"https://openalex.org/S1043257","display_name":"Acta Oncologica","issn_l":"0284-186X","issn":["0284-186X","1651-226X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Oncologica","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[{"id":"https://openalex.org/G6567454057","display_name":null,"funder_award_id":"ACF-2017-06-005","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"}],"funders":[{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320326375","display_name":"Hellenic Society of Medical Oncology","ror":"https://ror.org/02ar9bs92"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2783422013.pdf","grobid_xml":"https://content.openalex.org/works/W2783422013.grobid-xml"},"referenced_works_count":33,"referenced_works":["https://openalex.org/W846770500","https://openalex.org/W1776654207","https://openalex.org/W1964635588","https://openalex.org/W1972679105","https://openalex.org/W1991246148","https://openalex.org/W1996600303","https://openalex.org/W1999880202","https://openalex.org/W2010333260","https://openalex.org/W2022941077","https://openalex.org/W2026895719","https://openalex.org/W2069467434","https://openalex.org/W2114307213","https://openalex.org/W2114788594","https://openalex.org/W2115072149","https://openalex.org/W2128328462","https://openalex.org/W2139176803","https://openalex.org/W2143809951","https://openalex.org/W2147143600","https://openalex.org/W2154444715","https://openalex.org/W2199506938","https://openalex.org/W2326090948","https://openalex.org/W2331622677","https://openalex.org/W2439129042","https://openalex.org/W2557133906","https://openalex.org/W2570401594","https://openalex.org/W2586743405","https://openalex.org/W2616124688","https://openalex.org/W2675431728","https://openalex.org/W2727515049","https://openalex.org/W2741953965","https://openalex.org/W2742680816","https://openalex.org/W2746061356","https://openalex.org/W4211125721"],"related_works":["https://openalex.org/W2763901745","https://openalex.org/W2473579062","https://openalex.org/W2143809951","https://openalex.org/W1776654207","https://openalex.org/W1964589941","https://openalex.org/W2064201779","https://openalex.org/W1987546539","https://openalex.org/W2322114139","https://openalex.org/W1991246148","https://openalex.org/W2031095211"],"abstract_inverted_index":{"BACKGROUND:":[0],"Thromboembolic":[1],"events":[2],"(TEEs)":[3],"represent":[4],"a":[5,94,127,149,232],"significant":[6],"treatment":[7,227,279],"and":[8,38,68,83,96,113,138,209,278],"disease":[9],"complication":[10],"for":[11,29,35,270,274,293],"cancer":[12],"patients.":[13],"In":[14,88,224],"the":[15,20,180,210],"present":[16],"study":[17],"we":[18],"assessed":[19],"incidence":[21,304],"of":[22,174,212,235,246,253,305],"TEEs":[23,107,123],"in":[24,70,119],"patients":[25,52,91,104,120,294],"receiving":[26],"preoperative":[27,58],"chemotherapy":[28,292],"esophagogastric":[30,54,297],"adenocarcinoma.":[31],"The":[32],"risk":[33,172,234,251],"factors":[34,173],"TEE":[36,158],"development":[37],"their":[39],"impact":[40],"on":[41],"prognosis":[42],"were":[43,74,146,176,264],"further":[44],"analyzed.":[45],"MATERIAL":[46],"AND":[47],"METHODS:":[48],"Data":[49],"from":[50],"590":[51],"with":[53,60,105,121,148,160,231,295,301],"adenocarcinoma,":[55],"who":[56],"received":[57,85],"epirubicin-cisplatin":[59],"capecitabine":[61],"(ECX)":[62],"or":[63,159,200],"5-fluorouracil":[64],"(ECF)":[65],"between":[66],"2009":[67],"2016":[69],"three":[71],"UK":[72],"hospitals":[73],"retrospectively":[75],"collected.":[76],"RESULTS:":[77],"Twenty-one":[78],"percent":[79],"had":[80,93,110],"stomach":[81,181],"primary":[82,177],"98%":[84],"ECX":[86],"chemotherapy.":[87],"total,":[89],"52":[90],"(9%)":[92],"venous":[95,106,214],"22":[97],"(4%)":[98],"an":[99,249,265],"arterial":[100,122],"event.":[101],"Of":[102],"those":[103],"(vTTEs),":[108],"39":[109],"pulmonary":[111],"embolism":[112],"13":[114],"deep":[115],"vein":[116],"thrombosis,":[117],"whereas":[118],"(arTTEs),":[124],"7":[125],"developed":[126,131,135,140],"myocardial":[128],"infarct,":[129],"8":[130],"limb":[132],"ischemia,":[133],"4":[134],"cerebrovascular":[136],"accidents":[137],"3":[139],"superior":[141],"mesenteric":[142],"artery":[143],"thrombosis.":[144],"ArTEEs":[145],"associated":[147,230,300],"much":[150],"higher":[151],"inoperability":[152],"rate":[153],"compared":[154],"to":[155],"cases":[156],"without":[157],"vTEE":[161,236],"(77%":[162],"vs.":[163,165],"20%":[164],"31%,":[166],"respectively,":[167],"p":[168,188,197,206,221,241,259,286],"<":[169,189,287],".001).":[170,288],"Independent":[171],"vTEEs":[175],"site":[178],"being":[179,191],"(Odds":[182],"ratio":[183,282],"[OR]":[184],"3.24,":[185],"95%CI":[186,195,204,219,239,257,284],"1.72-6.12,":[187],".001),":[190],"overweight":[192],"(OR":[193,202,217,237,255],"3.11,":[194],"1.33-7.26,":[196],"=":[198,207,222,242,260],".009)":[199],"obese":[201],"4.52,":[203],"1.85-11.09,":[205],".001)":[208],"presence":[211],"central":[213],"access":[215],"device":[216],"3.40,":[218],"1.00-11.55,":[220],".050).":[223],"contrast,":[225],"anticoagulant":[226],"was":[228,248,299],"independently":[229],"lower":[233],"0.22,":[238],"0.06-0.83,":[240],".026).":[243],"Khorana":[244],"score":[245],"4-5":[247],"independent":[250,266],"factor":[252,269],"arTEE":[254],"6.38,":[256],"1.85-22.04,":[258],".003).":[261],"Finally,":[262],"arTEEs":[263,309],"poor":[267],"prognostic":[268],"OS,":[271],"when":[272],"adjusted":[273],"baseline":[275],"patient,":[276],"tumor":[277],"characteristics":[280],"(Hazard":[281],"3.02,":[283],"1.85-4.95,":[285],"CONCLUSION:":[289],"Preoperative":[290],"ECX/ECF":[291],"resectable":[296],"adenocarcinoma":[298],"relatively":[302],"high":[303],"TEEs.":[306],"However,":[307],"only":[308],"affected":[310],"patient":[311],"survival":[312],"outcomes.":[313]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2018-01-26T00:00:00"}